Skip to main content
. Author manuscript; available in PMC: 2013 Oct 23.
Published in final edited form as: Gene Ther. 2012 Apr 5;20(3):255–261. doi: 10.1038/gt.2012.31

Figure 4.

Figure 4

Antigen boost in combination with CPA did not accelerate decay of anti-MV or anti-VSV antibodies in immune mice. CD46 transgenic mice that were previously immunized with VSV-ΔG-GFP and MV were given MV/CPA, VSV-ΔG-GFP/CPA, MV/VSV-ΔG-GFP/CPA or saline/CPA. CPA was given 1 day before virus boost (four daily doses of 3 mg CPA per mouse). (a) Anti-MV antibody (Ab) and (b) anti-VSV Ab titers at the start (empty histograms) before CPA or 3 weeks post CPA treatment (gray histograms) are shown for each of the groups. N = 10 mice per group (mean ± s.e.m.). P-values (t-test) are shown. The asterisks indicate that the two groups are statistically different.